Table 2.
Distribution of Candida species in HIV/AIDS patients and non-HIV subjects with oropharyngeal candidiasis based on gender
| Candida species |
Male n (%)
|
Female n (%)
|
Total n (%)
|
95% CI
|
P-value | ||||
|---|---|---|---|---|---|---|---|---|---|
| HIV/AIDS patients | non-HIV subjects | HIV/AIDS patients | non-HIV subjects | HIV/AIDS patients | non-HIV subjects | HIV/AIDS patients | non-HIV subjects | ||
| C. albicans | 21 (25.93) | 10 (28.57) | 35 (43.21) | 2 (5.7) | 56 (69.14) | 12 (34.29) | 58.41-7814 | 20.84-50.85 | 0.11 |
| Total | 29 (35.8) | 28 (80) | 52 (64.2) | 7 (20) | 81 (100) | 35 (100) | 100 | 100 | - |
| C. krusei | 0 (0.0) | 18 (51.43) | 1 (1.235) | 5 (14.29) | 1 (1.235) | 23 (65.71) | 0.062-6.089 | 49.15-79.16 | 0.23 |
| C. parapsilosis | 2 (2.47) | 0 (0.0) | 2 (2.47) | 0 (0.0) | 4 (4.938 ) | 0 (0.0) | 1.569-11.91 | - | 0.18 |
| C. glabrata | 5 (6.173) | 0 (0.0) | 14 (17.28) | 0 (0.0) | 19 (23.46) | 0 (0.0) | 15.57-33.76 | - | 0.16 |
| C. kefyr | 1 (1.235) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (1.235) | 0 (0.0) | 0.062-6.089 | - | 0.42 |